Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Single-blind, Parallel Group, Clinical Evaluation of the Efficacy and Safety of Clindamycin 1% / Benzoyl Peroxide 3% and Azelaic Acid 20% in the Topical Treatment of Mild to Moderate Acne Vulgaris

NCT02058628 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02058628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02058628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Single-blind, Parallel Group, Clinical Evaluation of the Efficacy and Safety of Clindamycin 1% / Benzoyl Peroxide 3% and Azelaic Acid 20% in the Topical Treatment of Mild to Moderate Acne Vulgaris
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
February 21, 2014
Completion date
September 8, 2014
Enrollment
222 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris